Development Level

Tclin 2 | 613
Tchem 1 | 1,598

IMPC Phenotype

abnormal behavior 1 | 298
abnormal bone structure 1 | 187
abnormal eye morphology 1 | 68
abnormal gait 1 | 69
decreased cardiac output 1 | 3
decreased circulating alkaline... 1 | 46
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
embryonic lethality prior to t... 1 | 278
enlarged heart 1 | 210
increased bone mineral content 1 | 108
preweaning lethality, complete... 1 | 979
preweaning lethality, incomple... 1 | 499
thin ventricular wall 1 | 24

Disease

Carcinoma 3 | 11,493
breast carcinoma 3 | 1,638
ductal carcinoma in situ 3 | 1,745
invasive ductal carcinoma 3 | 2,951
osteosarcoma 3 | 7,950
primitive neuroectodermal tumor 3 | 3,035
Atherosclerosis 2 | 291
Atopic dermatitis 2 | 952
Cancer 2 | 2,499
Coronary artery disease 2 | 268
Crohn Disease 2 | 45
Diabetes Mellitus, Experimental 2 | 108
Diabetes Mellitus, Non-Insulin-Dependent 2 | 145
Diabetes Mellitus, Type 2 2 | 142
Diabetic dyslipidemia associated with type 2 diabetes mellitus 2 | 2
Dyslipidemias 2 | 27
Fatty Liver 2 | 70
Fatty liver disease 2 | 103
Heart disease 2 | 306
Hepatomegaly 2 | 285
Hyperglycemia 2 | 137
Hyperinsulinism 2 | 133
Hypertension 2 | 396
Hypertensive disease 2 | 292
Inflammation 2 | 120
Insulin Resistance 2 | 72
Lipid metabolism disorder 2 | 114
Liver disease 2 | 237
Liver neoplasms 2 | 130
Obesity 2 | 678
Reperfusion Injury 2 | 86
Schizophrenia 2 | 1,160
atypical teratoid/rhabdoid tumor 2 | 357
diabetes mellitus 2 | 1,728
group 3 medulloblastoma 2 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
medulloblastoma, large-cell 2 | 6,241
posterior fossa group B ependymoma 2 | 416
psoriasis 2 | 6,694
Abnormal pigmentation 1 | 25
Abnormality of the musculature 1 | 16
Acanthosis Nigricans 1 | 27
Acute Lung Injury 1 | 22
Adenocarcinoma 1 | 122
Advanced bone age 1 | 35
Barrett Esophagus 1 | 16
Bone Cysts 1 | 12
Broad feet 1 | 19
Congenital anomaly of neck 1 | 19
Decreased subcutaneous adipose tissue 1 | 13
Deformity of neck 1 | 19
Diabetes Mellitus, Noninsulin-Dependent 1 | 31
Familial hypercholesterolemia - heterozygous 1 | 6
Familial partial lipodystrophy 1 | 12
Generalized hirsutism 1 | 36
Gestational diabetes 1 | 26
Glioma 1 | 74
Glomerulonephritis 1 | 46
Growth hormone excess 1 | 14
High density lipoprotein decreased 1 | 10
Hyperlipidemia 1 | 43
Hyperlipoproteinemias 1 | 5
Hyperplasia of supraorbital margins 1 | 19
Hyperplasia of supraorbital ridge 1 | 19
Hypertriglyceridemia 1 | 17
Hypertriglyceridemia result 1 | 37
Hypertrophy of supraorbital margins 1 | 19
Hypertrophy of supraorbital ridge 1 | 19
Hyperuricemia 1 | 49
Hypoalphalipoproteinemias 1 | 10
Insulin resistant diabetes 1 | 13
Ischemia 1 | 28
Kidney Failure, Chronic 1 | 46
Large hand 1 | 18
Lipidoses 1 | 19
Lipodystrophy 1 | 40
Lipoidosis 1 | 19
Lymphoma, T-Cell 1 | 13
Malformation of the neck 1 | 19
Metabolic Diseases 1 | 10
Mixed hyperlipidemia 1 | 5
Myocardial Reperfusion Injury 1 | 37
Neoplasms 1 | 63
Non-alcoholic Fatty Liver Disease 1 | 42
Oligomenorrhea 1 | 16
Papillary thyroid carcinoma 1 | 43
Polycystic Kidney, Autosomal Dominant 1 | 7
Pre-Eclampsia 1 | 68
Precocious Puberty 1 | 28
Primary Prevention of Coronary Heart Disease 1 | 4
Primary physiologic amenorrhea 1 | 55
Prominent supraorbital ridges 1 | 19
Seasonal affective disorder 1 | 28
Skeletal muscle hypertrophy 1 | 16
Steatohepatitis 1 | 44
T-Cell Lymphoma 1 | 13
Thyroid Neoplasm 1 | 37
Thyroid Neoplasms 1 | 34
Xanthomatosis 1 | 12

Tissue

Blood and immune system 3 | 16,909
Cardiovascular System 3 | 15,192
Digestive Tract 3 | 17,369
Endocrine System 3 | 18,159
Female tissues 3 | 17,400
Liver and Pancreas 3 | 16,750
Male tissues 3 | 17,142
Nervous System 3 | 16,725
Respiratory system 3 | 16,393
Skin and soft tissues 3 | 17,230
Urinary Tract 3 | 16,678

Target Family

Nuclear Receptor 3 | 48

GO Process

negative regulation of recepto... 3 | 3
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Nuclear receptor subfamily 1 group D member 1 NR1D1 Tchem Nuclear Receptor -1.95952 81.6 389
Peroxisome proliferator-activated receptor gamma PPARG Tclin Nuclear Receptor -3.96393 9579.5 773
Peroxisome proliferator-activated receptor alpha PPARA Tclin Nuclear Receptor -3.37176 2457.9 501